Get the app
Industry

GitLab's founder went 'Founder Mode' on cancer — and it worked

Sid Sijbrandij used ChatGPT, RNA sequencing, and experimental therapies to beat osteosarcoma after standard treatments failed.

GitLab's founder went 'Founder Mode' on cancer — and it worked

When standard chemo, surgery, and radiation couldn't stop his osteosarcoma, GitLab co-founder Sid Sijbrandij built a personalized cancer-fighting stack. He uploaded RNA sequencing data into ChatGPT to identify overexpressed gene pathways, coordinated whole-genome sequencing (~$500), and used single-cell analysis via 10x Genomics to model his tumor.

The result: experimental FAP-targeting radioligand therapy in Germany, a personalized neoantigen mRNA vaccine, and CAR-T therapies in development. After treatment, T cells in his tumor jumped from 19% to 89%. By January 2026, scans showed no evidence of disease.

He's now founding a company to make this personalized medicine approach accessible beyond the wealthy — starting with affordable sequencing to replicate what he did.

Why it matters: This is a real-world proof-of-concept that AI-assisted medical reasoning can surface treatment paths that standard oncology misses — and it's moving from one founder's story toward a replicable model.

Sources

Independent coverage

Written by an AI pipeline from the sources above. Methodology · Report an error

The day's AI news, in one Telegram post.

The stories that matter for people who build with AI, with the source for every claim. Free, no spam.

Join on Telegram
The daily AI brief, on your phone.

Feed, daily deep-dive and bytes — readable offline, with push alerts for the topics you follow.

Get it on Google Play